
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Shares | 95.940 | 95.940 | 0.000 |
Bonds | 0.180 | 0.180 | 0.000 |
Convertible | 0.160 | 0.160 | 0.000 |
Preferred | 3.680 | 3.680 | 0.000 |
Other | 0.070 | 0.170 | 0.100 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 20.853 | 20.853 |
Price to Book | 4.300 | 4.300 |
Price to Sales | 2.078 | 2.078 |
Price to Cash Flow | 18.525 | 18.525 |
Dividend Yield | 0.721 | 0.721 |
5 Years Earnings Growth | 10.431 | 10.431 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.930 | 99.930 |
Financial Services | 0.070 | 0.070 |
Number of long holdings: 270
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 10.27 | 769.88 | +0.55% | |
UnitedHealth | US91324P1021 | 6.21 | 303.22 | +2.49% | |
Intuitive Surgical | US46120E6023 | 5.88 | 557.08 | -0.18% | |
Thermo Fisher Scientific | US8835561023 | 4.61 | 401.90 | +0.89% | |
Stryker | US8636671013 | 4.23 | 383.89 | +0.21% | |
Danaher | US2358511028 | 3.77 | 196.02 | +2.01% | |
argenx ADR | US04016X1019 | 3.72 | 585.93 | +0.92% | |
Merck&Co | US58933Y1055 | 2.55 | 78.97 | +1.74% | |
Boston Scientific | US1011371077 | 2.54 | 102.09 | -0.72% | |
Vertex | US92532F1003 | 2.42 | 450.50 | +1.51% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
TD North American Dividend I | 7.53B | 1.43 | 15.54 | 10.06 | ||
TD North American Dividend D USD | 7.53B | 1.83 | 16.72 | 10.97 | ||
TD U.S. Blue Chip Equity Fund D USD | 4.87B | -4.85 | 15.76 | - | ||
TD U.S. Blue Chip Equity Fund I USD | 4.87B | -5.26 | 14.62 | 11.27 | ||
TD US Index e | 3.24B | -3.32 | 17.56 | 13.40 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review